RITTER PHARMACEUTICALS INC 4
4 · RITTER PHARMACEUTICALS INC · Filed Oct 25, 2016
Insider Transaction Report
Form 4
Ritter Andrew J
DirectorPresident
Transactions
- Award
Non-qualified Stock Option (Right to Buy)
2016-10-25+140,044→ 140,044 totalExercise: $2.60Exp: 2026-10-25→ Common Stock (140,044 underlying)
Footnotes (1)
- [F1]The option vests ratably over 48 months following the public disclosure of top-line data results from the Issuer's Phase 2b/3 clinical trial.